ea0022p613 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010
Lupi Isabella
, Manetti Luca
, Caturegli Patrizio
, Menicagli Michele
, Bevilacqua Genersoso
, Bogazzi Fausto
, Martino Enio
Serum pituitary antibodies (Pit Abs) and tumor infiltrating lymphocytes (TILs) have been described in a small percentage of pituitary adenomas but their clinical significance remains unknown.Aim of the study was to assess Pit Abs and TILs prevalence in patients with pituitary adenomas and to determine their influence on the clinical outcome. In this prevalence caseĀcontrol study were enrolled 291 pituitary adenoma cases, (110 non-secreting, 30 ACTH-...